
Virtual Tumor Board: Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist
In this recorded virtual tumor board, faculty discuss the use of neoadjuvant and adjuvant immunotherapy for esophageal and gastric cancers and discuss how to properly incorporate immunotherapies into care plans based on the latest clinical trial data and recommendations. The role of biomarkers in identifying eligible patients and ongoing clinical trials that will further impact the use of immunotherapies in gastroesophageal cancers is also highlighted.

Virtual Tumor Board: Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist
Live Webinar
Faculty: G. Travis Clifton, MD (Moderator), Mihir M. Shah, MD (Panelist), Salma Jabbour, MD (Panelist), Howard Hochster, MD (Panelist), Onkar Khullar, MD, MSc (Panelist)
Release Date:
Expiration Date: December 06, 2021
CME/CE is no longer available for this activity

Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist
Webinar
A multidisciplinary panel of faculty discuss the use of neoadjuvant and adjuvant immunotherapy for esophageal and gastric cancers in this recorded virtual tumor board. Throughout the case discussions, faculty discuss how to properly incorporate immunotherapies into care plans based on the latest clinical trial data and recommendations. The faculty also highlight the role of biomarkers in identifying eligible patients and ongoing clinical trials that will further impact the use of immunotherapies in gastroesophageal cancers.
Faculty: G. Travis Clifton, MD (Moderator), Mihir M. Shah, MD (Panelist), Salma Jabbour, MD (Panelist), Howard Hochster, MD (Panelist), Onkar Khullar, MD, MSc (Panelist)
Release Date:
Expiration Date: December 22, 2022
CME/CE is no longer available for this activity